1. Home
  2. HRMY vs STAA Comparison

HRMY vs STAA Comparison

Compare HRMY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.65

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$25.20

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
STAA
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.2B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
STAA
Price
$37.65
$25.20
Analyst Decision
Strong Buy
Hold
Analyst Count
9
10
Target Price
$51.33
$24.56
AVG Volume (30 Days)
779.7K
1.6M
Earning Date
11-04-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$230,591,000.00
Revenue This Year
$23.11
N/A
Revenue Next Year
$16.15
$22.61
P/E Ratio
$11.94
N/A
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$13.50
52 Week High
$40.93
$30.81

Technical Indicators

Market Signals
Indicator
HRMY
STAA
Relative Strength Index (RSI) 56.93 49.14
Support Level $37.12 $23.03
Resistance Level $40.87 $26.18
Average True Range (ATR) 1.36 1.52
MACD -0.32 -0.01
Stochastic Oscillator 40.59 49.68

Price Performance

Historical Comparison
HRMY
STAA

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: